Heron Therapeutics (HRTX) Market Update
- Closing Price (07:11 AM CET, 22 Oct 2026): USD 0.34
- Down 2.86 % from the previous close.
- Shares Outstanding: 189.6 million.
- Market Capitalization: USD 67.3 million.
- 24‑Hour Trading Volume: USD 1.1 million.
- Year‑to‑Date Performance: Up 13.33 % since the end of the last month.
- 200‑Day Simple Moving Average: USD 0.74.
- 52‑Week High: USD 1.58 (1 Sep 2026).
- 52‑Week Low: USD 0.26 (21 Sep 2026).
24‑Hour Performance of Related Stocks
| Ticker | Current Price | % Change | Market Capitalization | Notes |
|---|---|---|---|---|
| KULR | USD 1.75 | +1.16 % | USD 80 million | — |
| NRDY | USD 6.24 | –0.79 % | USD 80.4 million | — |
| JRSH | USD 6.26 | –0.79 % | USD 80.1 million | P/E = 17.2 |
| BSIN | USD 1.50 | +3.45 % | USD 80.1 million | — |
| SERA | USD 2.03 | 0 % | USD 80.1 million | — |
Company Overview
Heron Therapeutics, Inc. is a biotechnology firm headquartered in San Diego, United States. The company specializes in proprietary biochronomer drug‑delivery technology designed to enhance the therapeutic profiles of injectable pharmaceuticals. In addition, Heron Therapeutics works on reformulating existing therapies to improve their efficacy and safety. The company is listed on the Nasdaq stock exchange and completed its initial public offering on August 26 1987. For further details, visit the company’s website at www.herontx.com .
